hrcak mascot   Srce   HID

Ostalo

Recombinant Activated Factor VII Controls Chemotherapy-Related Hemorrhage in Patients with Solid Intra-Abdominal Tumors: A Report of Three Pediatric Cases

Ernest Bilić
Ljubica Rajić
Ranka Femenić
Josip Konja
Katarina Vučić
Milivoj Novak
Miran Cvitković
Slobodan Galić
Nikola Krmek

Puni tekst: engleski, pdf (190 KB) str. 161-166 preuzimanja: 439* citiraj
APA 6th Edition
Bilić, E., Rajić, Lj., Femenić, R., Konja, J., Vučić, K., Novak, M., ... Krmek, N. (2009). Recombinant Activated Factor VII Controls Chemotherapy-Related Hemorrhage in Patients with Solid Intra-Abdominal Tumors: A Report of Three Pediatric Cases. Acta clinica Croatica, 48 (2), 161-166. Preuzeto s https://hrcak.srce.hr/40954
MLA 8th Edition
Bilić, Ernest, et al. "Recombinant Activated Factor VII Controls Chemotherapy-Related Hemorrhage in Patients with Solid Intra-Abdominal Tumors: A Report of Three Pediatric Cases." Acta clinica Croatica, vol. 48, br. 2, 2009, str. 161-166. https://hrcak.srce.hr/40954. Citirano 20.06.2021.
Chicago 17th Edition
Bilić, Ernest, Ljubica Rajić, Ranka Femenić, Josip Konja, Katarina Vučić, Milivoj Novak, Miran Cvitković, Slobodan Galić i Nikola Krmek. "Recombinant Activated Factor VII Controls Chemotherapy-Related Hemorrhage in Patients with Solid Intra-Abdominal Tumors: A Report of Three Pediatric Cases." Acta clinica Croatica 48, br. 2 (2009): 161-166. https://hrcak.srce.hr/40954
Harvard
Bilić, E., et al. (2009). 'Recombinant Activated Factor VII Controls Chemotherapy-Related Hemorrhage in Patients with Solid Intra-Abdominal Tumors: A Report of Three Pediatric Cases', Acta clinica Croatica, 48(2), str. 161-166. Preuzeto s: https://hrcak.srce.hr/40954 (Datum pristupa: 20.06.2021.)
Vancouver
Bilić E, Rajić Lj, Femenić R, Konja J, Vučić K, Novak M i sur. Recombinant Activated Factor VII Controls Chemotherapy-Related Hemorrhage in Patients with Solid Intra-Abdominal Tumors: A Report of Three Pediatric Cases. Acta clinica Croatica [Internet]. 2009 [pristupljeno 20.06.2021.];48(2):161-166. Dostupno na: https://hrcak.srce.hr/40954
IEEE
E. Bilić, et al., "Recombinant Activated Factor VII Controls Chemotherapy-Related Hemorrhage in Patients with Solid Intra-Abdominal Tumors: A Report of Three Pediatric Cases", Acta clinica Croatica, vol.48, br. 2, str. 161-166, 2009. [Online]. Dostupno na: https://hrcak.srce.hr/40954. [Citirano: 20.06.2021.]

Sažetak
Recombinant activated factor VII (rFVIIa; NovoSeven, Novo Nordisk, Bagsvaerd, Denmark) is used predominantly for the treatment of bleeding in patients with hemophilia and inhibitors, and in patients with traumatic injury. There are also literature reports of its use in chemotherapy-related bleeding in leukemia patients and intra- or postoperative bleeding in patients with solid tumors. We describe three pediatric patients where rFVIIa was successfully used to manage bleeding following the failure of conventional hemostatic treatments during chemotherapy for intra-abdominal tumors (hepatoblastoma, rhabdomyosarcoma and non-classified malignant sarcoma). Recombinant FVIIa proved effective and maintained hemostasis in two of three cases, with no evidence for toxic or adverse events in any of the treated patients.

Ključne riječi
Blood loss - surgical; Blood loss - prevention and control; Factor VII - adverse effects; Abdominal neoplasms - complications; Abdominal neoplasms - chemotherapy; Abdominal neoplasms - surgery; Child

Hrčak ID: 40954

URI
https://hrcak.srce.hr/40954

[hrvatski]

Posjeta: 925 *